Javascript must be enabled to continue!
258-OR: Perioperative Glucose Management and Amputation Outcomes
View through CrossRef
Introduction and Objective: Patients with diabetes have a 15-34% lifetime risk of foot ulcerations and complications from these ulcers are a leading cause of nontraumatic amputations in the United States. Elevated perioperative glucose (>140 mg/dL or A1c ≥8%) is associated with complications in elective surgeries, but limited data exists on its impact on nonelective amputations. This study aims to assess the effect of perioperative glucose levels on outcomes in patients with diabetes undergoing lower extremity amputations after infectious cases.
Methods: This two-year retrospective chart review at a large tertiary health system identified 186 patients who underwent lower extremity amputations between January 1, 2021, and December 31, 2022. Glucose levels were measured preoperatively (120-30 minutes before incision), intraoperatively, and postoperatively (30-120 minutes after surgery). Non-eligible patients included non-diabetic related amputations, incomplete follow-up (<6 months), and missing glucose measurements. Outcomes such as healing time, postoperative infection, and hospital readmissions were assessed.
Results: 65 patients met eligibility. Postoperative glucose >180 mg/dL significantly delayed healing by ~ 1.6 weeks (p= 0.0255). Healing time was also influenced by amputation level, with transmetatarsal amputations delaying healing by ~ 2.9 weeks (p<0.001). Postoperative infection and peripheral arterial disease (PAD) added ~2.1 weeks (p <0.001) and ~ 1.6 weeks (p = 0.0046) respectively to the average healing time. A1c levels and preoperative glucose levels were non-significant.
Conclusion: Postoperative glucose levels >180 mg/dL delayed healing in diabetic patients undergoing amputations. Healing time was also influenced by amputation level, post operative infection, and PAD. These findings emphasize tight perioperative glucose control and lay the groundwork for future research to optimize glucose management in high-risk procedures.
Disclosure
C. Girgis: None. S. Behme: None. I. Gaynanova: None. B.M. Schmidt: None.
American Diabetes Association
Title: 258-OR: Perioperative Glucose Management and Amputation Outcomes
Description:
Introduction and Objective: Patients with diabetes have a 15-34% lifetime risk of foot ulcerations and complications from these ulcers are a leading cause of nontraumatic amputations in the United States.
Elevated perioperative glucose (>140 mg/dL or A1c ≥8%) is associated with complications in elective surgeries, but limited data exists on its impact on nonelective amputations.
This study aims to assess the effect of perioperative glucose levels on outcomes in patients with diabetes undergoing lower extremity amputations after infectious cases.
Methods: This two-year retrospective chart review at a large tertiary health system identified 186 patients who underwent lower extremity amputations between January 1, 2021, and December 31, 2022.
Glucose levels were measured preoperatively (120-30 minutes before incision), intraoperatively, and postoperatively (30-120 minutes after surgery).
Non-eligible patients included non-diabetic related amputations, incomplete follow-up (<6 months), and missing glucose measurements.
Outcomes such as healing time, postoperative infection, and hospital readmissions were assessed.
Results: 65 patients met eligibility.
Postoperative glucose >180 mg/dL significantly delayed healing by ~ 1.
6 weeks (p= 0.
0255).
Healing time was also influenced by amputation level, with transmetatarsal amputations delaying healing by ~ 2.
9 weeks (p<0.
001).
Postoperative infection and peripheral arterial disease (PAD) added ~2.
1 weeks (p <0.
001) and ~ 1.
6 weeks (p = 0.
0046) respectively to the average healing time.
A1c levels and preoperative glucose levels were non-significant.
Conclusion: Postoperative glucose levels >180 mg/dL delayed healing in diabetic patients undergoing amputations.
Healing time was also influenced by amputation level, post operative infection, and PAD.
These findings emphasize tight perioperative glucose control and lay the groundwork for future research to optimize glucose management in high-risk procedures.
Disclosure
C.
Girgis: None.
S.
Behme: None.
I.
Gaynanova: None.
B.
M.
Schmidt: None.
Related Results
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
The frequency and Risk Factors of Re-amputation in Diabetic Foot Disease at a tertiary care hospital.
The frequency and Risk Factors of Re-amputation in Diabetic Foot Disease at a tertiary care hospital.
Introduction: The prevalence of diabetes in Pakistan is 11.7% and the preva-lence of diabetic foot in Pakistan is 13.9% with amputation rate of as high as 48%. Re-amputation carrie...
Gaps in Vascular Evaluation Before Major Lower-Extremity Amputation Among Medicare Beneficiaries With Chronic Limb-Threatening Ischemia
Gaps in Vascular Evaluation Before Major Lower-Extremity Amputation Among Medicare Beneficiaries With Chronic Limb-Threatening Ischemia
ABSTRACT
Background
Guidelines recommend vascular specialist evaluation and revascularization consideration before major amputa...
FACTORS THAT INFLUENCE THE USAGE OF PROSTHESES AMONG PERSONS WITH LOWER LIMB AMPUTATION IN THE KUMASI METROPOLIS
FACTORS THAT INFLUENCE THE USAGE OF PROSTHESES AMONG PERSONS WITH LOWER LIMB AMPUTATION IN THE KUMASI METROPOLIS
There has been numerous technological advancements in dealing with major etiologies of lower limb amputation but lower limb amputation has been on the rise. According to Amoah et a...
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Objective: To explore on the antitumor effect of gefitinib and rapamycin and possible mechanism in normal glucose and high lactic acid microenvironment. Methods: Hela cells are cul...
Intravenous glucose infusion affects nitrogen retention in sheep
Intravenous glucose infusion affects nitrogen retention in sheep
To investigate the effect of intravenous glucose infusion on nitrogen (N) retention, two experiments were conducted in 2 phases . The first phase (Exp 1) was to establish the time ...
442-P: Diabetic Foot Ulcer Amputation Is Associated with Two-Fold Increased Risk of Incident Cardiovascular Disease—A Korean National Health Information Database Study
442-P: Diabetic Foot Ulcer Amputation Is Associated with Two-Fold Increased Risk of Incident Cardiovascular Disease—A Korean National Health Information Database Study
Diabetic Foot Ulcer (DFU), a critical complication of diabetes, impacts about 8% of individuals with diabetes and leads to a 20% risk of lower extremity amputation. People with DFU...
417-P: Diabetic Foot Ulcer Amputation Increases the Risk of Severe Renal and Retinal Microvascular Complications—A Korean National Health Information Database Study
417-P: Diabetic Foot Ulcer Amputation Increases the Risk of Severe Renal and Retinal Microvascular Complications—A Korean National Health Information Database Study
Diabetic foot ulcer (DFU) and subsequent amputation represents significant health burden associated with diabetes. It is widely recognized that individuals with diabetic end stage ...

